Govindarajan Prasanna
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Govindarajan Prasanna has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Pu Jing
Shanghai Food Safety and Engineering Technology Research Center, Bor S. Luh Food Safety Research Center, Key Lab of Urban Agriculture (South), School of Agriculture & Biology, Shanghai Jiao Tong University, Shanghai 200240, China; Shanghai Jiao Tong University Sichuan Research Institute,619#, Jicui Street, Tianfu New Area, Sichuan Province, China
6 shared publications - Saraswathi Nambiappan Thangavel
Molecular Biophysics Lab, School of Chemical and Biotechnology, SASTRA Deemed to be University
6 shared publications T. Marimuthu
Goverment Hospital
2 shared publicationsA. Ujwal
Sastra University
1 shared publicationG. Koushik Kumar
Molecular Biophysics Laboratory, School of Chemical and Biotechnology, Shanmuga Arts Science Technology Research Academy University, Thanjavur, 613401, India
1 shared publicationJian-Hua Liu
College of Resources and Environment Engineering, Yibin University, Yibin 644000, Sichuan, China
1 shared publication
Latest Publications
- 1 January 2021
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 534, 950-956
Self-assembly of N-terminal Alzheimer’s β-amyloid and its inhibition
- 1 January 2021
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 534, 950-956
Self-assembly of N-terminal Alzheimer’s β-amyloid and its inhibition
- 23 May 2019
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 38 (6) , 1-10
Molecular interaction of cyanidin-3-O-glucoside with ovalbumin: insights from spectroscopic, molecular docking and in vitro digestive studies
Anthocyanins bound with proteins have influence on the digestibility of proteins. In this study, the interaction between cyanidin-3-O-glucoside (C3G) and ovalbumin (OVA) was investigated through multi-spectroscopy and molecular docking. The interactive effect of C3G on OVA digestibility was estimated by an in vitro digestion model. Fluorescence studies indicated that C3G quenched the fluorescence of OVA in a static mode, where the binding constants (Ka) at 298, 308, and 318 K were above 105 M−1, indicating a strong binding affinity of C3G with OVA. The negative values of thermodynamic parameters (ΔG, ΔH and ΔS) revealed a spontaneous binding process, where hydrogen and van der Waals forces were involved in stabilizing the OVA-C3G complex. The secondary structure of OVA was modified by C3G binding, with augmented β-sheet (21.5% to 25.1%) and diminished α-helix (23.3% to 21.6%). Besides, C3G substantially inhibited the digestion of OVA in pancreatin solution whereas it had negligible effect on pepsin. Furthermore, molecular docking and cleavage site prediction studies showed that the hydrogen binding sites of C3G are not near to the cleavage sites of pepsin but partially overlap trypsin cleavages sites in OVA, which might lead to an inhibited effect on pancreatic digestion. These results provide a better understanding of the anthocyanin-protein interactions and their effect on the protein digestibility.
- 23 May 2019
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 38 (6) , 1-10
Molecular interaction of cyanidin-3-O-glucoside with ovalbumin: insights from spectroscopic, molecular docking and in vitro digestive studies
Anthocyanins bound with proteins have influence on the digestibility of proteins. In this study, the interaction between cyanidin-3-O-glucoside (C3G) and ovalbumin (OVA) was investigated through multi-spectroscopy and molecular docking. The interactive effect of C3G on OVA digestibility was estimated by an in vitro digestion model. Fluorescence studies indicated that C3G quenched the fluorescence of OVA in a static mode, where the binding constants (Ka) at 298, 308, and 318 K were above 105 M−1, indicating a strong binding affinity of C3G with OVA. The negative values of thermodynamic parameters (ΔG, ΔH and ΔS) revealed a spontaneous binding process, where hydrogen and van der Waals forces were involved in stabilizing the OVA-C3G complex. The secondary structure of OVA was modified by C3G binding, with augmented β-sheet (21.5% to 25.1%) and diminished α-helix (23.3% to 21.6%). Besides, C3G substantially inhibited the digestion of OVA in pancreatin solution whereas it had negligible effect on pepsin. Furthermore, molecular docking and cleavage site prediction studies showed that the hydrogen binding sites of C3G are not near to the cleavage sites of pepsin but partially overlap trypsin cleavages sites in OVA, which might lead to an inhibited effect on pancreatic digestion. These results provide a better understanding of the anthocyanin-protein interactions and their effect on the protein digestibility.
- 1 November 2018
- Published by Elsevier in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
- Vol. 204, 708-716
Spectroscopic and molecular modelling studies on glycation modified bovine serum albumin with cyanidin-3-O-glucoside
- 1 November 2018
- Published by Elsevier in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
- Vol. 204, 708-716
Spectroscopic and molecular modelling studies on glycation modified bovine serum albumin with cyanidin-3-O-glucoside
- 1 April 2018
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 643, 50-56
Cyanidin-3- O -glucoside functions like chemical chaperone and attenuates the glycation mediated amyloid formation in albumin
- 1 April 2018
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 643, 50-56
Cyanidin-3- O -glucoside functions like chemical chaperone and attenuates the glycation mediated amyloid formation in albumin
- 1 December 2017
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 105, 965-972
Spectrofluorimetric and molecular docking studies on the interaction of cyanidin-3-O-glucoside with whey protein, β-lactoglobulin
- 1 December 2017
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 105, 965-972
Spectrofluorimetric and molecular docking studies on the interaction of cyanidin-3-O-glucoside with whey protein, β-lactoglobulin
- 12 March 2017
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 36 (4) , 819-829
Hydroxy methoxy benzaldehyde fromSesbania grandilforainhibits the advanced glycation end products (AGEs)-mediated fibrillation in hemoglobin
The present study was aimed to identify the active anti-glycation constituent from the leaves of Sesbania grandiflora. Characterization of the active constituent resulted in the identification of hydroxy methoxy benzaldehyde (HMB). The potential of HMB as anti-glycation lead was analyzed by fluorescence spectroscopy, fluorescence microscopy, scanning electron microscopy (SEM) and molecular interaction studies. Our results suggested that HMB inhibited formation of early (HbA1c) and advanced glycation end products (AGEs). The amyloid-like fibrillation in hemoglobin was also inhibited by HMB. SEM images indicated the protective effect against the formation of acanthocytes. Molecular docking studies showed that HMB was interacting with hemoglobin through hydrogen bonds with Arg141, Tyr140, and Thr137. Our findings suggest that HMB could be a better anti-glycation lead molecule towards novel AGEs inhibitors.
- 12 March 2017
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 36 (4) , 819-829
Hydroxy methoxy benzaldehyde fromSesbania grandilforainhibits the advanced glycation end products (AGEs)-mediated fibrillation in hemoglobin
The present study was aimed to identify the active anti-glycation constituent from the leaves of Sesbania grandiflora. Characterization of the active constituent resulted in the identification of hydroxy methoxy benzaldehyde (HMB). The potential of HMB as anti-glycation lead was analyzed by fluorescence spectroscopy, fluorescence microscopy, scanning electron microscopy (SEM) and molecular interaction studies. Our results suggested that HMB inhibited formation of early (HbA1c) and advanced glycation end products (AGEs). The amyloid-like fibrillation in hemoglobin was also inhibited by HMB. SEM images indicated the protective effect against the formation of acanthocytes. Molecular docking studies showed that HMB was interacting with hemoglobin through hydrogen bonds with Arg141, Tyr140, and Thr137. Our findings suggest that HMB could be a better anti-glycation lead molecule towards novel AGEs inhibitors.
- 1 February 2017
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 95, 121-125
Linolenic acid prevents early and advanced glycation end-products (AGEs) modification of albumin
- 1 February 2017
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 95, 121-125
Linolenic acid prevents early and advanced glycation end-products (AGEs) modification of albumin
- 1 September 2015
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 34 (5) , 943-951
Aspartic acid functions as carbonyl trapper to inhibit the formation of advanced glycation end products by chemical chaperone activity
Advanced glycation end products (AGEs) were implicated in pathology of numerous diseases. In this study, we present the bioactivity of aspartic acid (Asp) to inhibit the AGEs. Hemoglobin and bovine serum albumin (BSA) were glycated with glucose, fructose, and ribose in the presence and absence of Asp (100–200 μM). HbA1c inhibition was investigated using human blood and characterized by micro-column ion exchange chromatography. The effect of methyl glyoxal (MG) on hemoglobin and BSA was evaluated by fluorescence spectroscopy and gel electrophoresis. The effect of MG on red blood cells morphology was characterized by scanning electron micrographs. Molecular docking was performed on BSA with Asp. Asp is capable of inhibiting the formation of fluorescent AGEs by reacting with the reducing sugars. The presence of Asp as supplement in whole blood reduced the HbA1c% from 8.8 to 6.1. The presence of MG showed an increase in fluorescence and the presence of Asp inhibited the glycation thereby the fluorescence was quenched. MG also affected the electrophoretic mobility of hemoglobin and BSA by forming high molecular weight aggregates. Normal RBCs showed typical biconcave shape. MG modified RBCs showed twisted and elongated shape whereas the presence of ASP tends to protect RBC from twisting. Asp interacted with arginine residues of bovine serum albumin particularly ARG 194, ARG 198, and ARG 217 thereby stabilized the protein complex. We conclude that Asp has dual functions as a chemical chaperone to stabilize protein and as a dicarbonyl trapper, and thereby it can prevent the complications caused by glycation.
- 1 September 2015
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 34 (5) , 943-951
Aspartic acid functions as carbonyl trapper to inhibit the formation of advanced glycation end products by chemical chaperone activity
Advanced glycation end products (AGEs) were implicated in pathology of numerous diseases. In this study, we present the bioactivity of aspartic acid (Asp) to inhibit the AGEs. Hemoglobin and bovine serum albumin (BSA) were glycated with glucose, fructose, and ribose in the presence and absence of Asp (100–200 μM). HbA1c inhibition was investigated using human blood and characterized by micro-column ion exchange chromatography. The effect of methyl glyoxal (MG) on hemoglobin and BSA was evaluated by fluorescence spectroscopy and gel electrophoresis. The effect of MG on red blood cells morphology was characterized by scanning electron micrographs. Molecular docking was performed on BSA with Asp. Asp is capable of inhibiting the formation of fluorescent AGEs by reacting with the reducing sugars. The presence of Asp as supplement in whole blood reduced the HbA1c% from 8.8 to 6.1. The presence of MG showed an increase in fluorescence and the presence of Asp inhibited the glycation thereby the fluorescence was quenched. MG also affected the electrophoretic mobility of hemoglobin and BSA by forming high molecular weight aggregates. Normal RBCs showed typical biconcave shape. MG modified RBCs showed twisted and elongated shape whereas the presence of ASP tends to protect RBC from twisting. Asp interacted with arginine residues of bovine serum albumin particularly ARG 194, ARG 198, and ARG 217 thereby stabilized the protein complex. We conclude that Asp has dual functions as a chemical chaperone to stabilize protein and as a dicarbonyl trapper, and thereby it can prevent the complications caused by glycation.
- 9 December 2014
- Published by Springer Nature in Chinese Journal of Integrative Medicine
- Vol. 21 (6) , 445-452
Structural basis for complementary and alternative medicine: Phytochemical interaction with non-structural protein 2 protease-a reverse engineering strategy
To understand the druggability of the bioactive compounds from traditional herbal formulations “Nilavembu Kudineer” and “Swasthya Raksha Amruta Peya” to heal chikungunya virus (CHIKV) infection. The efficiency of twenty novel chemical entities from “Nilavembu Kudineer” and “Swasthya Raksha Amruta Peya” to inhibit CHIKV infection in silico were evaluated. Ligands were prepared using Ligprep module of Schrödinger. Active site was identified using SiteMap program. Grid box was generated using receptor grid generation wizard. Molecular docking was carried out using Grid Based Ligand Docking with Energetics (GLIDE) program. Molecular docking studies showed that among twenty compounds, andrographoside, deoxyandrographoside, neoandrographolide, 14-deoxy-11-oxoandrographolide, butoxone and oleanolic acid showed GLIDE extra precision (XP) score of −9.10, −8.72, −8.25, −7.38, −7.28 and −7.01, respectively which were greater than or comparable with chloroquine (reference compound) XP score (−7.08) and were found to interact with the key residues GLU 1043, LYS 1045, GLY 1176, LEU 1203, HIS 1222 and LYS 1239 which were characteristic functional unit crucial for replication of CHIKV. The binding affinity and the binding mode of chemical entities taken from herbal formulations with non-structural protein 2 protease were understood and our study provided a novel strategy in the development and design of drugs for CHIKV infection.
- 9 December 2014
- Published by Springer Nature in Chinese Journal of Integrative Medicine
- Vol. 21 (6) , 445-452
Structural basis for complementary and alternative medicine: Phytochemical interaction with non-structural protein 2 protease-a reverse engineering strategy
To understand the druggability of the bioactive compounds from traditional herbal formulations “Nilavembu Kudineer” and “Swasthya Raksha Amruta Peya” to heal chikungunya virus (CHIKV) infection. The efficiency of twenty novel chemical entities from “Nilavembu Kudineer” and “Swasthya Raksha Amruta Peya” to inhibit CHIKV infection in silico were evaluated. Ligands were prepared using Ligprep module of Schrödinger. Active site was identified using SiteMap program. Grid box was generated using receptor grid generation wizard. Molecular docking was carried out using Grid Based Ligand Docking with Energetics (GLIDE) program. Molecular docking studies showed that among twenty compounds, andrographoside, deoxyandrographoside, neoandrographolide, 14-deoxy-11-oxoandrographolide, butoxone and oleanolic acid showed GLIDE extra precision (XP) score of −9.10, −8.72, −8.25, −7.38, −7.28 and −7.01, respectively which were greater than or comparable with chloroquine (reference compound) XP score (−7.08) and were found to interact with the key residues GLU 1043, LYS 1045, GLY 1176, LEU 1203, HIS 1222 and LYS 1239 which were characteristic functional unit crucial for replication of CHIKV. The binding affinity and the binding mode of chemical entities taken from herbal formulations with non-structural protein 2 protease were understood and our study provided a novel strategy in the development and design of drugs for CHIKV infection.